Gelteq (GELS) Common Equity (2023 - 2025)
Gelteq (GELS) posted Common Equity of $9.3 million for Q4 2025, down 7.88% on a QoQ basis from $10.1 million in Q2 2025, and down 24.13% year-over-year from $12.3 million in Q4 2024.
Analysis
Gelteq (GELS) Common Equity (2023 - 2025) Analysis & Trends
Gelteq has reported Common Equity for 3 years, with the latest figure at $9.3 million in Q4 2025.
- On a quarterly basis, Common Equity fell 24.13% year-over-year to $9.3 million in Q4 2025; TTM through Dec 2025 was $9.3 million, a 24.13% decrease from a year earlier, with the FY2025 full-year figure at $10.1 million, up 2.12% from the prior year.
- Common Equity was $9.3 million for Q4 2025 at Gelteq, down from $10.1 million in the prior quarter.
- The five-year high for Common Equity was $12.5 million in Q2 2023, with the low at $9.3 million in Q4 2025.
- Average Common Equity over 3 years is $10.8 million, with a median of $10.1 million recorded in 2025.
- The largest YoY upside for Common Equity was 1.63% in 2025 against a maximum downside of 24.13% in 2025.
- Over 3 years, Common Equity stood at $12.5 million in 2023, then slipped by 1.45% to $12.3 million in 2024, then retreated by 24.13% to $9.3 million in 2025.
- The last three Common Equity figures came in at $9.3 million (Q4 2025), $10.1 million (Q2 2025), and $12.3 million (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Natural Alternatives International | 12.05 Mn | 2.78 Mn | 383,000.00 | 63.11 Mn |
| 2 | Gelteq | 7.42 Mn | 7.37 Mn | - | 9.32 Mn |
| 3 | Nexgel | 121,250.28 | -1.07 Mn | 1.11 Mn | 5.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 9.32 Mn |
| Jun 30, 2025 | 10.12 Mn |
| Dec 31, 2024 | 12.29 Mn |
| Jun 30, 2024 | 9.96 Mn |
| Jun 30, 2023 | 12.47 Mn |